| Symbol | IMDX |
|---|---|
| Name | INSIGHT MOLECULAR DIAGNOSTICS INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Address | 2 INTERNATIONAL PLAZA DR.,SUITE 510, NASHVILLE, 37217, United States |
| Telephone | +1 949 409-7600 |
| Fax | — |
| — | |
| Website | https://www.oncocyte.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001642380 |
| Description | Insight Molecular Diagnostics Inc., or iMDx (formerly Oncocyte Corporation), is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.imdxinc.com/ for more information. Additional info from NASDAQ: |
iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant
Read more(99% Neutral) INSIGHT MOLECULAR DIAGNOSTICS INC. (IMDX) Announces New Board Appointment
Read moreFavorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry
Read moreDirector SILVERMAN LOU 🟢 acquired 26.9K shares of Insight Molecular Diagnostics Inc. (IMDX) Transaction Date: Jun 11, 2026 | Filing ID: 028755
Read moreDirector Last Andrew J. 🟢 acquired 26.9K shares of Insight Molecular Diagnostics Inc. (IMDX) Transaction Date: Jun 11, 2026 | Filing ID: 028754
Read moreDirector Arno Andrew 🟢 acquired 32.3K shares of Insight Molecular Diagnostics Inc. (IMDX) Transaction Date: Jun 11, 2026 | Filing ID: 028753
Read moreIMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation
Read moreiMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress
Read more(30% Negative) INSIGHT MOLECULAR DIAGNOSTICS INC. (IMDX) Reports Q2 2026 Financial Results
Read moreIMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
Read more